Table 2.
Derivation cohort | Tuning cohort | Geographic validation cohort | ||||
---|---|---|---|---|---|---|
HR (CI 95%) | p-value | HR (CI 95%) | p-value | HR (CI 95%) | p-value | |
Low | reference | reference | reference | |||
Intermediate-1 | 1·26 (1·17, 1·36) | < 0·0001 | 1·25 (1·14, 1·37) | < 0·0001 | 1·48 (1·17, 1·88) | 0·0011 |
Intermediate-2 | 1·53 (1·42, 1·66) | < 0·0001 | 1·52 (1·38, 1·67) | < 0·0001 | 1·62 (1·27, 2·08) | < 0·0001 |
High | 2·03 (1·86, 2·22) | < 0·0001 | 2·04 (1·83, 2·28) | < 0·0001 | 2·61 (2·01, 3·39) | < 0·0001 |
Very High | 2·87 (2·63, 3·13) | < 0·0001 | 2·90 (2·62, 3·22) | < 0·0001 | 3·70 (2·88, 4·74) | < 0·0001 |
The full multivariable results for OS, relapse incidence and non-relapse mortality are presented in appendix p. 5, 7–8
OS – overall survival; CI – confidence interval; HR – hazard ratio